Ardelyx (ARDX) Common Equity (2013 - 2026)
Ardelyx (ARDX) reported Common Equity of $148.6 million for Q1 2026, up 2.02% on a YoY basis from $145.7 million in Q1 2025, and down 10.98% quarter-over-quarter from $166.9 million in Q4 2025.
Ardelyx (ARDX) Common Equity (2013 - 2026) Analysis & Trends
Ardelyx has reported Common Equity for 14 years, with the latest figure at $148.6 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 2.02% year-over-year to $148.6 million; the trailing twelve-month figure through Mar 2026 stood at $148.6 million (up 2.02% YoY), and the FY2025 full-year result was $166.9 million, down 3.66% from the prior year.
- Common Equity for Q1 2026 stood at $148.6 million, down from $166.9 million in the prior quarter.
- The five-year high for Common Equity was $191.2 million in Q3 2023, with the low at $53.0 million in Q2 2022.
- Historically, Common Equity has averaged $133.7 million across 5 years, with a median of $147.0 million in 2024.
- Annual changes were most pronounced in 2022 — Common Equity slumped 54.88% — and 2023, when it soared 185.91%.
- Ardelyx's Common Equity stood at $98.3 million in 2022, then surged by 69.65% to $166.8 million in 2023, then gained by 3.88% to $173.3 million in 2024, then dropped by 3.66% to $166.9 million in 2025, then slipped by 10.98% to $148.6 million in 2026.
- The last three Common Equity figures came in at $148.6 million (Q1 2026), $166.9 million (Q4 2025), and $154.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 148.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.62 Mn |
| Dec 31, 2025 | 166.95 Mn |
| Sep 30, 2025 | 154.28 Mn |
| Jun 30, 2025 | 139.53 Mn |
| Mar 31, 2025 | 145.68 Mn |
| Dec 31, 2024 | 173.29 Mn |
| Sep 30, 2024 | 158.30 Mn |
| Jun 30, 2024 | 146.99 Mn |
| Mar 31, 2024 | 150.89 Mn |
| Dec 31, 2023 | 166.82 Mn |
| Sep 30, 2023 | 191.16 Mn |
| Jun 30, 2023 | 123.16 Mn |
| Mar 31, 2023 | 125.42 Mn |
| Dec 31, 2022 | 98.33 Mn |
| Sep 30, 2022 | 66.86 Mn |
| Jun 30, 2022 | 53.04 Mn |
| Mar 31, 2022 | 64.19 Mn |
| Dec 31, 2021 | 82.62 Mn |
| Sep 30, 2021 | 81.43 Mn |
| Jun 30, 2021 | 117.57 Mn |